Literature DB >> 4008099

Therapeutic application of a radiolabelled monoclonal antibody in nude mice xenografted with human neuroblastoma: tumoricidal effects and distribution studies.

D H Jones, A Goldman, I Gordon, J Pritchard, B J Gregory, J T Kemshead.   

Abstract

Monoclonal antibody UJ13A radiolabelled with isotopes of iodine has been shown to selectively localize to human neuroblastoma xenografts. When 131I-UJ13A conjugates were given to nude mice at high doses (100-150 microCi), tumours temporarily disappeared, only to regrow. No selection for neuroblastoma cells that were UJ13A - negative was observed. Distribution studies on mice receiving radiolabelled UJ13A demonstrated the antibody is rapidly lost from the blood of animals. This cannot be accounted for by selective uptake into xenografts or any other mouse organ examined. We concluded there is a rapid equilibration of isotope between intra- and extravascular spaces in the animal. The rapid, biphasic loss of UJ13A from the blood of mice may explain why so little injected antibody can target to the human tumour xenografts.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4008099     DOI: 10.1002/ijc.2910350604

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Carcinomatous meningitis: antibody-guided therapy with I-131 HMFG1.

Authors:  R P Moseley; J C Benjamin; R D Ashpole; N M Sullivan; J A Bullimore; H B Coakham; J T Kemshead
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-03       Impact factor: 10.154

2.  Dosimetry of intrathecal iodine131 monoclonal antibody in cases of neoplastic meningitis.

Authors:  R B Richardson; J T Kemshead; A G Davies; G E Staddon; P C Jackson; H B Coakham; L S Lashford
Journal:  Eur J Nucl Med       Date:  1990

3.  Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments.

Authors:  F Buchegger; C Pfister; K Fournier; F Prevel; M Schreyer; S Carrel; J P Mach
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

4.  Radioimmunolocalization of human brain tumours: biodistribution of radiolabelled monoclonal antibody UJ13A.

Authors:  R B Richardson; A G Davies; S P Bourne; G E Staddon; D H Jones; J T Kemshead; H B Coakham
Journal:  Eur J Nucl Med       Date:  1986

5.  Immunohistological characterisation of retinoblastoma and related ocular tissue.

Authors:  J F Tarlton; D L Easty
Journal:  Br J Ophthalmol       Date:  1990-03       Impact factor: 4.638

6.  Radioimmunotherapy of transplanted small cell lung cancer with 131I-labelled monoclonal antibody.

Authors:  S Yoneda; M Fujisawa; J Watanabe; T Okabe; F Takaku; T Homma; K Yoshida
Journal:  Br J Cancer       Date:  1988-09       Impact factor: 7.640

7.  Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancer.

Authors:  R H Begent; J A Ledermann; A J Green; K D Bagshawe; S J Riggs; F Searle; P A Keep; T Adam; R G Dale; M G Glaser
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

8.  Dose escalation with repeated intrathecal injections of 131I-labelled MAbs for the treatment of central nervous system malignancies.

Authors:  J T Kemshead; K Hopkins; B Pizer; V Papanastassiou; H Coakham; J Bullimore; C Chandler
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

Review 9.  Uses and limitations of monoclonal antibodies (MoAbs) in the treatment of malignant disease: a review.

Authors:  J T Kemshead; K Hopkins
Journal:  J R Soc Med       Date:  1993-04       Impact factor: 18.000

10.  Immunoscintigraphy of small-cell lung cancer xenografts with anti neural cell adhesion molecule monoclonal antibody, 123C3: improvement of tumour uptake by internalisation.

Authors:  H B Kwa; J Wesseling; A H Verhoeven; N van Zandwijk; J Hilkens
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.